tiprankstipranks
Trending News
More News >
Biogen (BIIB)
NASDAQ:BIIB
US Market

Biogen (BIIB) Ratios

Compare
4,989 Followers

Biogen Ratios

BIIB's free cash flow for Q3 2025 was $0.64. For the 2025 fiscal year, BIIB's free cash flow was decreased by $ and operating cash flow was $0.25. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.72 1.35 2.00 2.99 1.83
Quick Ratio
2.04 0.90 1.26 2.58 1.51
Cash Ratio
1.17 0.43 0.31 1.04 0.53
Solvency Ratio
0.22 0.20 0.14 0.32 0.16
Operating Cash Flow Ratio
0.75 0.52 0.45 0.42 0.85
Short-Term Operating Cash Flow Coverage
0.00 1.64 10.31 0.00 3.64
Net Current Asset Value
$ -2.06B$ -3.88B$ -5.19B$ -1.37B$ -5.06B
Leverage Ratios
Debt-to-Assets Ratio
0.23 0.24 0.27 0.27 0.32
Debt-to-Equity Ratio
0.36 0.40 0.50 0.49 0.69
Debt-to-Capital Ratio
0.27 0.28 0.33 0.33 0.41
Long-Term Debt-to-Capital Ratio
0.26 0.21 0.31 0.32 0.36
Financial Leverage Ratio
1.60 1.68 1.81 1.83 2.18
Debt Service Coverage Ratio
12.30 1.36 5.65 15.10 1.94
Interest Coverage Ratio
9.40 9.95 8.49 9.41 11.20
Debt to Market Cap
0.24 0.28 0.19 0.16 0.20
Interest Debt Per Share
46.73 47.22 52.42 47.22 52.70
Net Debt to EBITDA
0.78 1.42 2.65 0.73 2.15
Profitability Margins
Gross Profit Margin
70.12%76.12%74.24%77.61%80.79%
EBIT Margin
27.34%24.00%19.14%37.73%18.20%
EBITDA Margin
34.98%30.96%24.17%42.83%22.64%
Operating Profit Margin
24.47%25.74%21.32%22.81%25.87%
Pretax Profit Margin
19.07%19.70%13.18%35.31%15.89%
Net Profit Margin
16.11%16.87%11.81%29.95%14.17%
Continuous Operations Profit Margin
16.11%16.87%11.81%29.11%15.73%
Net Income Per EBT
84.48%85.63%89.54%84.83%89.16%
EBT Per EBIT
77.92%76.54%61.83%154.81%61.44%
Return on Assets (ROA)
5.51%5.82%4.33%12.41%6.52%
Return on Equity (ROE)
9.25%9.76%7.85%22.76%14.20%
Return on Capital Employed (ROCE)
9.43%11.06%8.96%10.90%14.51%
Return on Invested Capital (ROIC)
7.96%8.79%7.94%8.94%13.33%
Return on Tangible Assets
12.02%13.74%9.47%17.97%9.79%
Earnings Yield
6.10%7.33%3.10%7.57%4.35%
Efficiency Ratios
Receivables Turnover
5.40 5.18 4.68 4.76 5.60
Payables Turnover
7.22 5.45 6.28 4.64 3.58
Inventory Turnover
1.35 0.94 1.00 1.69 1.56
Fixed Asset Turnover
2.93 2.74 2.64 2.75 2.90
Asset Turnover
0.34 0.34 0.37 0.41 0.46
Working Capital Turnover Ratio
1.91 3.62 1.98 2.02 3.28
Cash Conversion Cycle
287.33 392.19 383.96 213.29 197.09
Days of Sales Outstanding
67.62 70.50 77.93 76.65 65.20
Days of Inventory Outstanding
270.23 388.71 364.14 215.38 233.82
Days of Payables Outstanding
50.53 67.02 58.11 78.74 101.94
Operating Cycle
337.85 459.21 442.07 292.03 299.02
Cash Flow Ratios
Operating Cash Flow Per Share
16.74 19.74 10.69 9.53 24.41
Free Cash Flow Per Share
15.53 17.27 8.54 7.85 22.43
CapEx Per Share
1.20 2.47 2.15 1.67 1.98
Free Cash Flow to Operating Cash Flow
0.93 0.87 0.80 0.82 0.92
Dividend Paid and CapEx Coverage Ratio
13.93 7.99 4.97 5.69 12.34
Capital Expenditure Coverage Ratio
13.93 7.99 4.97 5.69 12.34
Operating Cash Flow Coverage Ratio
0.37 0.43 0.21 0.21 0.48
Operating Cash Flow to Sales Ratio
0.25 0.30 0.16 0.14 0.33
Free Cash Flow Yield
8.63%11.29%3.30%2.84%9.35%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
16.40 13.65 32.25 13.21 22.99
Price-to-Sales (P/S) Ratio
2.64 2.30 3.81 3.96 3.26
Price-to-Book (P/B) Ratio
1.45 1.33 2.53 3.01 3.26
Price-to-Free Cash Flow (P/FCF) Ratio
11.59 8.86 30.30 35.26 10.69
Price-to-Operating Cash Flow Ratio
10.75 7.75 24.20 29.07 9.83
Price-to-Earnings Growth (PEG) Ratio
3.38 0.34 -0.52 0.13 -0.40
Price-to-Fair Value
1.45 1.33 2.53 3.01 3.26
Enterprise Value Multiple
8.33 8.86 18.40 9.97 16.54
Enterprise Value
29.12B 26.54B 43.73B 43.43B 41.11B
EV to EBITDA
8.33 8.86 18.40 9.97 16.54
EV to Sales
2.92 2.74 4.45 4.27 3.74
EV to Free Cash Flow
12.79 10.55 35.39 38.06 12.29
EV to Operating Cash Flow
11.87 9.23 28.27 31.37 11.30
Tangible Book Value Per Share
16.27 3.75 1.50 39.84 19.97
Shareholders’ Equity Per Share
124.20 114.73 102.28 92.14 73.51
Tax and Other Ratios
Effective Tax Rate
0.16 0.14 0.10 0.18 0.03
Revenue Per Share
68.12 66.41 67.97 70.02 73.65
Net Income Per Share
10.97 11.20 8.02 20.97 10.44
Tax Burden
0.84 0.86 0.90 0.85 0.89
Interest Burden
0.70 0.82 0.69 0.94 0.87
Research & Development to Revenue
0.21 0.26 0.25 0.22 0.23
SG&A to Revenue
0.06 0.24 0.25 0.23 0.23
Stock-Based Compensation to Revenue
0.03 0.03 0.03 0.02 0.02
Income Quality
1.53 1.76 1.33 0.47 2.11
Currency in USD